ANTIHYPERTENSIVE AND RENAL VASODILATOR EFFECT OF DILTIAZEM IN DOCA-SALT HYPERTENSIVE DOG

被引:1
作者
ZIMMERMAN, BG
GOERING, JL
RAICH, PC
机构
关键词
D O I
10.1097/00005344-198806000-00015
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
引用
收藏
页码:730 / 735
页数:6
相关论文
共 27 条
[1]   EFFECTS OF THE CALCIUM-ANTAGONIST NICARDIPINE ON RENAL-FUNCTION AND RENIN RELEASE IN DOGS [J].
ABE, Y ;
KOMORI, T ;
MIURA, K ;
TAKADA, T ;
IMANISHI, M ;
OKAHARA, T ;
YAMAMOTO, K .
JOURNAL OF CARDIOVASCULAR PHARMACOLOGY, 1983, 5 (02) :254-259
[2]   LACK OF EFFECT OF NIFEDIPINE ON COUNTERREGULATORY MECHANISMS IN ESSENTIAL-HYPERTENSION [J].
BRUUN, NE ;
IBSEN, H ;
NIELSEN, F ;
NIELSEN, MD ;
MOELBAK, AG ;
HARTLING, OJ .
HYPERTENSION, 1986, 8 (08) :655-661
[3]   EFFECTS OF INTRARENAL INFUSION OF CALCIUM ENTRY BLOCKERS IN ANESTHETIZED DOGS [J].
DIETZ, JR ;
DAVIS, JO ;
FREEMAN, RH ;
VILLARREAL, D ;
ECHTENKAMP, SF .
HYPERTENSION, 1983, 5 (04) :482-488
[4]   PHYSIOLOGICAL-ASPECTS OF PRIMARY HYPERTENSION [J].
FOLKOW, B .
PHYSIOLOGICAL REVIEWS, 1982, 62 (02) :347-504
[5]   STUDIES ON SODIUM AND CALCIUM CONTENTS OF CARDIOVASCULAR TISSUE IN EXPERIMENTAL-HYPERTENSION [J].
FURUTA, Y .
JAPANESE CIRCULATION JOURNAL-ENGLISH EDITION, 1977, 41 (01) :19-28
[6]   PREVENTION OF DOCA-SALT HYPERTENSION WITH THE CALCIUM BLOCKER NITRENDIPINE [J].
HALL, CE ;
HUNGERFORD, S .
CLINICAL AND EXPERIMENTAL HYPERTENSION PART A-THEORY AND PRACTICE, 1983, 5 (05) :721-728
[7]   INHIBITION OF DOC-SALT AND ADRENAL-REGENERATION HYPERTENSION WITH THE CALCIUM BLOCKER NIFEDIPINE [J].
HALL, CE ;
HUNGERFORD, S .
CLINICAL AND EXPERIMENTAL HYPERTENSION PART A-THEORY AND PRACTICE, 1982, 4 (07) :1217-1230
[8]   DISSOCIATION OF RENAL BLOOD-FLOW AND FILTRATION-RATE AUTOREGULATION BY RENIN DEPLETION [J].
HALL, JE ;
GUYTON, AC ;
COWLEY, AW .
AMERICAN JOURNAL OF PHYSIOLOGY, 1977, 232 (03) :F215-F221
[9]   ANTIHYPERTENSIVE THERAPY WITH DILTIAZEM AND COMPARISON WITH HYDROCHLOROTHIAZIDE [J].
INOUYE, IK ;
MASSIE, BM ;
BENOWITZ, N ;
SIMPSON, P ;
LOGE, D .
AMERICAN JOURNAL OF CARDIOLOGY, 1984, 53 (11) :1588-1592
[10]  
ISHIKAWA H, 1978, ARZNEIMITTEL-FORSCH, V28-1, P402